Sodium Bicarbonate Tablet
NDC Package 0904-7261-61
Package Information
Sodium Bicarbonate tablets is do not use the maximum dosage for more than 2 weeks tablets may be swallowed whole or dissolved in water prior to use adults 60 years of age and over: 1-2 tablets every 4 hours, not more than 12 tablets in 24 hours adults under 60 years of age: 1-4 tablets every 4 hours, not more than 24 tablets in 24 hours. This formulation utilizes a tablet delivery system. Marketed by Major Pharmaceuticals, this product is identified by NDC 0904-7261 and is authorized under FDA application M001.
Identification & Billing
- RxCUI: 198861 - sodium bicarbonate 650 MG Oral Tablet
- RxCUI: 198861 - NaHCO3 650 MG Oral Tablet
- RxCUI: 198861 - sodium bicarbonate 10 Grains Oral Tablet
- RxCUI: 198861 - sodium bicarbonate 648 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0904 - Major Pharmaceuticals
- 0904-7261 - Sodium Bicarbonate
- 0904-7261-61 - 10 BLISTER PACK in 1 BOX, UNIT-DOSE / 10 TABLET in 1 BLISTER PACK
- 0904-7261 - Sodium Bicarbonate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0904-7261-61 identifies a specific commercial package of 10 blister pack in 1 box, unit-dose / 10 tablet in 1 blister pack of Sodium Bicarbonate, a human over the counter drug labeled by Major Pharmaceuticals. This tablet is formulated for oral use and contains sodium bicarbonate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Major Pharmaceuticals on October 26, 2022. The current certification is valid through December 31, 2026.
How is this Major Pharmaceuticals product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00904726161. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 10 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.